What do peptides like BPC-157 do, and are they safe?

BPC-157 is a small peptide (a fragment of protein) that occurs naturally in gastric juice. In animal research, conducted almost exclusively in rodents, it consistently shows beneficial effects on the healing of tendons, ligaments and muscle tissue. All published animal studies report faster and better tissue healing. That is remarkably consistent, but it involves only laboratory animals.

In lab studies with tendon cells, BPC-157 does what it does in animals: it accelerates cell migration (cells move more quickly to the site where repair is needed) and protects cells against damage from oxygen radicals. Direct cell growth is not stimulated. It most likely works through an influence on blood vessel formation and on the signalling systems that drive cell movement, but exactly how this works in humans has not been studied.

In humans, the evidence is very thin. There is one small case series in which knee patients received an injection of BPC-157 and reported less pain. However, this study had no control group and had serious methodological shortcomings. Nothing is known in humans about dose, duration of treatment or effective indications.

Even less can be said about safety. A pilot study with two participants found no side effects after intravenous administration, but two people over three days tells us almost nothing about what it does over the longer term. Long-term safety is entirely unknown. TB-500, a related peptide found in comparable recovery products, is furthermore on the banned substances list.

In short: BPC-157 is interesting as a research compound, but far from ready for self-administration or clinical use. Anyone considering it does not know what dose is safe, how long it can be used, or what the long-term risks are. That data simply does not yet exist.